Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2022 ASCO Gastrointestinal Cancers Symposium
2021 ASH Annual Meeting & Exposition
2021 San Antonio Breast Cancer Symposium
2021 Lynn Sage Breast Cancer Symposium
NCCN 2021 Virtual Congress: Hematologic Malignancies
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2016 ASH Annual Meeting
«
1
»
Advertisement
Advertisement
Jan
23
Today In Oncology
No Significant Benefit for Pevonedistat Plus Azacitidine in Higher-Risk Myelodysplastic Syndrome
Pretreatment Cardiovascular Disease and Events During Follow-up in Patients Receiving Curative-Intent Chemoradiation for Esophageal Cancer
Pembrolizumab in Previously Treated Patients With MSI-H/dMMR Endometrial Cancer
Erdafitinib for Patients With Advanced Urothelial Carcinoma and FGFR Alterations
Does Early Locoregional Therapy for the Primary Site Improve Survival in Newly Diagnosed Metastatic Breast Cancer
View More
Advertisement
